![](/img/cover-not-exists.png)
Tu1670 USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE
Lai, Michelle, Broestl, Jeremy, Juneja, Kavita, Milligan, Scott, Radtchenko, Janna, Younossi, Zobair M., Afdhal, Nezam H.Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)34283-9
Date:
May, 2020
File:
PDF, 357 KB
2020